{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:24:29Z","timestamp":1792016669002,"version":"4.4.0"},"reference-count":196,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jconrel.2022.09.058","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T23:23:18Z","timestamp":1665012198000},"page":"638-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases"],"prefix":"10.1016","volume":"351","author":[{"given":"Debashish","family":"Paramanick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena Devi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.09.058_bb0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1146\/annurev-biochem-061516-045049","article-title":"Propagation of protein aggregation in neurodegenerative diseases","volume":"88","author":"Vaquer-Alicea","year":"2019","journal-title":"Annu. Rev. Biochem."},{"issue":"April","key":"10.1016\/j.jconrel.2022.09.058_bb0010","first-page":"1","article-title":"Nanoformulations of herbal extracts in treatment of neurodegenerative disorders","volume":"8","author":"Moradi","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"3","key":"10.1016\/j.jconrel.2022.09.058_bb0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/alz.12328","article-title":"2021 Alzheimer\u2019s disease facts and figures special report Race, Ethnicity and Alzheimer\u2019s in America","volume":"17","author":"Alzheimer\u2019\u2019s Association","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0025","author":"A. D. International"},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"issue":"June","key":"10.1016\/j.jconrel.2022.09.058_bb0035","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.biopha.2018.06.147","article-title":"A molecular approach in drug development for Alzheimer\u2019s disease","volume":"106","author":"Agatonovic-Kustrin","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.jconrel.2022.09.058_bb0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: pharmacology and toxicology","volume":"11","author":"Colovi\u0107","year":"2013","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00213-007-0944-3","article-title":"Dose-related effects of the acetylcholinesterase inhibitor tacrine on cocaine and food self-administration in rats","volume":"196","author":"Grasing","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0050","article-title":"Therapeutic potential of phytoconstituents in management of Alzheimer\u2019s disease","volume":"2021","author":"Singh","year":"2021","journal-title":"Evid.-based Compl. Altern. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2022.09.058_bb0055","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejpb.2008.07.005","article-title":"Preparation of estradiol chitosan AChE for improving nasal absorption and brain targeting","volume":"70","author":"Wang","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.630055","article-title":"Nanomedicine: a promising way to manage Alzheimer\u2019s disease","volume":"9","author":"Khan","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"7","key":"10.1016\/j.jconrel.2022.09.058_bb0065","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1007\/s12035-015-9390-0","article-title":"Dissecting complex and multifactorial nature of alzheimer\u2019s disease pathogenesis: a clinical, genomic, and systems biology perspective","volume":"53","author":"Talwar","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of amyloid hypothesis and Tau hypothesis in Alzheimer\u2019s Disease","volume":"12","author":"Kametani","year":"2018","journal-title":"Front. Neurosci."},{"issue":"7","key":"10.1016\/j.jconrel.2022.09.058_bb0075","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jconrel.2022.09.058_bb0080","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer\u2019s disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-6606-4-3","article-title":"APP processing in Alzheimer\u2019s disease","volume":"4","author":"Zhang","year":"2011","journal-title":"Mol. Brain"},{"issue":"7","key":"10.1016\/j.jconrel.2022.09.058_bb0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2183\/pjab.89.321","article-title":"Metabolism of amyloid \u03b2 peptide and pathogenesis of Alzheimer\u2019s disease","volume":"89","author":"Saido","year":"2013","journal-title":"Proc. Jpn. Acad. Ser. B"},{"issue":"11","key":"10.1016\/j.jconrel.2022.09.058_bb0095","doi-asserted-by":"crossref","first-page":"292","DOI":"10.15698\/cst2018.11.162","article-title":"Making the final cut: pathogenic amyloid-\u03b2 peptide generation by \u03b3-secretase","volume":"2","author":"Steiner","year":"2018","journal-title":"Cell Stress"},{"issue":"s1","key":"10.1016\/j.jconrel.2022.09.058_bb0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1471-4159.2011.07476.x","article-title":"Developing \u03b2-secretase inhibitors for treatment of Alzheimer\u2019s disease","volume":"120","author":"Ghosh","year":"2012","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.jconrel.2022.09.058_bb0105","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.bmc.2008.12.067","article-title":"Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and \u03b2-secretase","volume":"17","author":"Zhu","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijpharm.2017.07.080","article-title":"Anti-Alzheimer\u2019s potential of berberine using surface decorated multi-walled carbon nanotubes: a preclinical evidence","volume":"530","author":"Lohan","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2022.09.058_bb0115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1021\/jf803072r","article-title":"Amyloid-degrading ability of nattokinase from bacillus subtilis natto","volume":"57","author":"Hsu","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0120","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.2147\/IJN.S144545","article-title":"Development of surface-engineered PLGA nanoparticulate-delivery system of Tet-1-conjugated nattokinase enzyme for inhibition of A\u03b240 plaques in Alzheimer\u2019s disease","volume":"12","author":"Bhatt","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0125","series-title":"Methods of Behavior Analysis in Neuroscience","article-title":"Transgenic mouse models of Alzheimer\u2019s disease: behavioral testing and considerations","author":"Bryan","year":"2009"},{"issue":"7","key":"10.1016\/j.jconrel.2022.09.058_bb0130","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","article-title":"Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study","volume":"68","author":"Edison","year":"2007","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jconrel.2022.09.058_bb0135","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00259-008-0833-y","article-title":"Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer\u2019s disease","volume":"35","author":"Li","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0140","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nicl.2013.02.006","article-title":"Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer\u2019s disease","volume":"2","author":"Ch\u00e9telat","year":"2013","journal-title":"NeuroImage Clin."},{"issue":"5534","key":"10.1016\/j.jconrel.2022.09.058_bb0145","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","article-title":"Enhanced neurofibrillary degeneration in transgenic mice expressing mutant Tau and APP","volume":"293","author":"Lewis","year":"2001","journal-title":"Science (80)"},{"issue":"6532","key":"10.1016\/j.jconrel.2022.09.058_bb0150","article-title":"Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies","volume":"vol. 371","author":"Chang","year":"2021","journal-title":"Science (80)"},{"issue":"11","key":"10.1016\/j.jconrel.2022.09.058_bb0155","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s00018-005-5597-y","article-title":"Glycogen synthase kinase 3\u03b2 and Alzheimer\u2019s disease: pathophysiological and therapeutic significance","volume":"63","author":"Balaraman","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2022.09.058_bb0160","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4088\/JCP.08m04606","article-title":"Lithium trial in Alzheimer\u2019s disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study","volume":"70","author":"Hampel","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.jconrel.2022.09.058_bb0165","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3233\/JAD-201069","article-title":"Associations between caffeine consumption, cognitive decline, and dementia: a systematic review","volume":"78","author":"Chen","year":"2020","journal-title":"J. Alzheimers Dis."},{"issue":"24","key":"10.1016\/j.jconrel.2022.09.058_bb0170","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.1016\/j.bmcl.2013.09.021","article-title":"6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3\u03b2 inhibitors","volume":"23","author":"Uehara","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.jconrel.2022.09.058_bb0175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: the therapeutic challenge for neurodegenerative disease","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2022.09.058_bb0180","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bcp.2013.12.008","article-title":"Tau-aggregation inhibitor therapy for Alzheimer\u2019s disease","volume":"88","author":"Wischik","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.jconrel.2022.09.058_bb0185","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1074\/jbc.M410984200","article-title":"Anthraquinones inhibit Tau aggregation and dissolve Alzheimer\u2019s paired helical filaments in vitro and in cells","volume":"280","author":"Pickhardt","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.jconrel.2022.09.058_bb0190","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M408714200","article-title":"Inhibition of heparin-induced Tau filament formation by phenothiazines, polyphenols, and porphyrins","volume":"280","author":"Taniguchi","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-020-00626-1","article-title":"Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer\u2019s disease","volume":"18","author":"Gao","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0200","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nlm.2013.08.001","article-title":"Free and nanoencapsulated curcumin suppress \u03b2-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt\/GSK-3\u03b2 signaling pathway","volume":"106","author":"Hoppe","year":"2013","journal-title":"Neurobiol. Learn. Mem."},{"issue":"6150","key":"10.1016\/j.jconrel.2022.09.058_bb0205","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/bmj.2.6150.1457","article-title":"Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia","volume":"2","author":"Perry","year":"1978","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.jconrel.2022.09.058_bb0210","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.102.041616","article-title":"The cholinergic hypothesis of age and Alzheimer\u2019s disease-related cognitive deficits: recent challenges and their implications for novel drug development","volume":"306","author":"Terry","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2017.08.016","article-title":"WITHDRAWN: Revisiting the cholinergic hypothesis in Alzheimer\u2019s disease: emerging evidence from translational and clinical research","author":"Hampel","year":"2017","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.jconrel.2022.09.058_bb0220","first-page":"307","article-title":"Formulation development, systematic optimization of PLGA-CS-Tween 80 nanoparticles of Rivastigmine Tartrate for treatment of Alzheimer\u2019s disease","volume":"7","author":"Kinjal","year":"2015","journal-title":"Sch. Res. Libr."},{"issue":"4","key":"10.1016\/j.jconrel.2022.09.058_bb0225","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3109\/10717544.2015.1089956","article-title":"Galantamine-loaded solid\u2013lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations","volume":"23","author":"Misra","year":"2016","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.rdc.2009.12.007","article-title":"Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus","volume":"36","author":"Aranow","year":"2010","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0235","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12951-018-0356-z","article-title":"Memantine loaded PLGA PEGylated nanoparticles for Alzheimer\u2019s disease: in vitro and in vivo characterization","volume":"16","author":"S\u00e1nchez-L\u00f3pez","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0240","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3762\/bjnano.11.72","article-title":"Key for crossing the BBB with nanoparticles: the rational design","volume":"11","author":"Lombardo","year":"2020","journal-title":"Beilstein J. Nanotechnol."},{"issue":"6","key":"10.1016\/j.jconrel.2022.09.058_bb0245","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00018-018-2982-x","article-title":"Intracellular transport and regulation of transcytosis across the blood\u2013brain barrier","volume":"76","author":"Villase\u00f1or","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.01019","article-title":"Transcytosis to cross the blood brain barrier, new advancements and challenges","volume":"12","author":"Pulgar","year":"2019","journal-title":"Front. Neurosci."},{"issue":"9","key":"10.1016\/j.jconrel.2022.09.058_bb0255","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s11095-007-9379-0","article-title":"Blood\u2013brain barrier transport of therapeutics via receptor-mediation","volume":"24","author":"Jones","year":"2007","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0260","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1146\/annurev-pharmtox-010814-124852","article-title":"Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier","volume":"55","author":"Lajoie","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0265","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11373-006-9121-7","article-title":"Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain","volume":"14","author":"Huang","year":"2007","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2022.09.058_bb0270","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1021\/nn300240p","article-title":"Receptor-mediated delivery of magnetic nanoparticles across the blood\u2013brain barrier","volume":"6","author":"Qiao","year":"2012","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2022.09.058_bb0275","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejpb.2008.08.021","article-title":"Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood\u2013brain barrier (BBB)","volume":"71","author":"Ulbrich","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"10","key":"10.1016\/j.jconrel.2022.09.058_bb0280","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1357-2725(99)00070-9","article-title":"The transferrin receptor: role in health and disease","volume":"31","author":"Ponka","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.jconrel.2022.09.058_bb0285","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1471-4159.2007.04976.x","article-title":"Iron trafficking inside the brain","volume":"103","author":"Moos","year":"2007","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.jconrel.2022.09.058_bb0290","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/acs.molpharmaceut.8b00870","article-title":"Transferrin receptor-mediated uptake at the blood\u2013brain barrier is not impaired by Alzheimer\u2019s disease neuropathology","volume":"16","author":"Bourassa","year":"2019","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.jconrel.2022.09.058_bb0295","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0300","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/exnr.2001.7541","article-title":"Downregulation of microglial activation by apolipoprotein e and apoe-mimetic peptides","volume":"167","author":"Laskowitz","year":"2001","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0305","doi-asserted-by":"crossref","first-page":"2000092","DOI":"10.1002\/adtp.202000092","article-title":"From adsorption to covalent bonding: apolipoprotein E functionalization of polymeric nanoparticles for drug delivery across the blood\u2013brain barrier","volume":"4","author":"Hartl","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0310","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/869269","article-title":"Drug delivery systems, CNS protection, and the blood brain barrier","volume":"2014","author":"Upadhyay","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.jconrel.2022.09.058_bb0315","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/bit.21120","article-title":"Humanization of anti-human insulin receptor antibody for drug targeting across the human blood\u2013brain barrier","volume":"96","author":"Boado","year":"2007","journal-title":"Biotechnol. Bioeng."},{"issue":"2","key":"10.1016\/j.jconrel.2022.09.058_bb0320","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/ijms20020381","article-title":"Review of current strategies for delivering alzheimer\u2019s disease drugs across the blood-brain barrier","volume":"20","author":"Wong","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fneng.2013.00007","article-title":"The blood-brain barrier: an engineering perspective","volume":"6","author":"Wong","year":"2013","journal-title":"Front. Neuroeng."},{"issue":"7","key":"10.1016\/j.jconrel.2022.09.058_bb0330","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood\u2013brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0335","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semcdb.2015.01.002","article-title":"Anatomy and physiology of the blood\u2013brain barrier","volume":"38","author":"Serlin","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"issue":"16","key":"10.1016\/j.jconrel.2022.09.058_bb0340","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1074\/jbc.M010897200","article-title":"Glucose Transporter Asymmetries in the Bovine Blood-Brain Barrier","volume":"276","author":"Simpson","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.jconrel.2022.09.058_bb0345","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nn.3966","article-title":"GLUT1 reductions exacerbate Alzheimer\u2019s disease vasculo-neuronal dysfunction and degeneration","volume":"18","author":"Winkler","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"18","key":"10.1016\/j.jconrel.2022.09.058_bb0350","doi-asserted-by":"crossref","first-page":"10118","DOI":"10.3390\/ijms221810118","article-title":"Design and development of nanomaterial-based drug carriers to overcome the blood\u2013brain barrier by using different transport mechanisms","volume":"22","author":"Song","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2022.09.058_bb0355","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/ana.22318","article-title":"Glut1\/SLC2A1 is crucial for the development of the blood-brain barrier in vivo","volume":"68","author":"Zheng","year":"2010","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0360","doi-asserted-by":"crossref","first-page":"12860","DOI":"10.1038\/s41598-019-49009-z","article-title":"l-type amino acid transporter 1 (LAT1\/Lat1)-utilizing prodrugs can improve the delivery of drugs into neurons, astrocytes and microglia","volume":"9","author":"Huttunen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0365","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/IJN.S23771","article-title":"Investigation of glucose-modifed liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting","volume":"7","author":"Xie","year":"2012","journal-title":"Int. J. Nanomedicine"},{"issue":"12","key":"10.1016\/j.jconrel.2022.09.058_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081043","article-title":"Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitro","volume":"8","author":"Gromnicova","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jconrel.2022.09.058_bb0375","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1021\/ja309812z","article-title":"Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency","volume":"135","author":"Lesniak","year":"2013","journal-title":"J. Am. Chem. Soc."},{"issue":"1\u20133","key":"10.1016\/j.jconrel.2022.09.058_bb0380","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0169-409X(00)00139-3","article-title":"Delivery of peptides and proteins through the blood\u2013brain barrier","volume":"46","author":"Bickel","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2022.09.058_bb0385","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.biomaterials.2012.09.047","article-title":"Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.jconrel.2022.09.058_bb0390","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.2217\/nnm.15.29","article-title":"PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting","volume":"10","author":"Monsalve","year":"2015","journal-title":"Nanomedicine"},{"issue":"3","key":"10.1016\/j.jconrel.2022.09.058_bb0395","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/iai.64.3.926-932.1996","article-title":"In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis","volume":"64","author":"Miyakawa","year":"1996","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.jconrel.2022.09.058_bb0400","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1208\/ps040426","article-title":"Peptide delivery to the brain via adsorptive-mediated endocytosis: Advances with SynB vectors","volume":"4","author":"Drin","year":"2002","journal-title":"AAPS PharmSci"},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0405","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0022-3565(24)29672-5","article-title":"Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity","volume":"296","author":"Rousselle","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"35","key":"10.1016\/j.jconrel.2022.09.058_bb0410","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/21\/35\/355102","article-title":"Characterization of endocytosis and exocytosis of cationic nanoparticles in airway epithelium cells","volume":"21","author":"Dombu","year":"2010","journal-title":"Nanotechnology"},{"issue":"5","key":"10.1016\/j.jconrel.2022.09.058_bb0415","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/cbdd.12586","article-title":"Cationic albumin-conjugated chelating agent as a novel brain drug delivery system in neurodegeneration","volume":"86","author":"Kamalinia","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"issue":"2","key":"10.1016\/j.jconrel.2022.09.058_bb0420","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1039\/C1NJ20444K","article-title":"The biodistribution of maltotriose modified poly(propylene imine) (PPI) dendrimers conjugated with fluorescein\u2014proofs of crossing blood\u2013brain\u2013barrier","volume":"36","author":"Janaszewska","year":"2012","journal-title":"New J. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0425","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/157341311794480291","article-title":"Cationized albumin conjugated solid lipid nanoparticles as vectors for brain delivery of an anti-cancer drug","volume":"7","author":"Agarwal","year":"2011","journal-title":"Curr. Nanosci."},{"issue":"3","key":"10.1016\/j.jconrel.2022.09.058_bb0430","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3390\/ijms21031066","article-title":"The clustering of mApoE anti-amyloidogenic peptide on nanoparticle surface does not alter its performance in controlling beta-amyloid aggregation","volume":"21","author":"Corti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2022.09.058_bb0435","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3390\/ma15030804","article-title":"Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders","volume":"15","author":"Bhattacharya","year":"2022","journal-title":"Materials (Basel)."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood\u2013brain barrier: an overview","volume":"16","author":"Ballabh","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"11","key":"10.1016\/j.jconrel.2022.09.058_bb0445","doi-asserted-by":"crossref","DOI":"10.2174\/1567205014666170203125008","article-title":"Nanotechnology for Alzheimer Disease","volume":"14","author":"Leszek","year":"2017","journal-title":"Curr. Alzheimer Res."},{"issue":"10","key":"10.1016\/j.jconrel.2022.09.058_bb0450","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1007\/s12274-018-2067-z","article-title":"Delivery systems for theranostics in neurodegenerative diseases","volume":"11","author":"Li","year":"2018","journal-title":"Nano Res."},{"issue":"7","key":"10.1016\/j.jconrel.2022.09.058_bb0455","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2174\/1389450120666191118123151","article-title":"Alzheimer\u2019s disease targeted nano-based drug delivery systems","volume":"21","author":"Altinoglu","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5578574","article-title":"Therapeutic potential of phytoconstituents in management of Alzheimer\u2019s disease","volume":"2021","author":"Singh","year":"2021","journal-title":"Evid.-Based Compl. Altern. Med."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0465","article-title":"A systematic review of minor phytocannabinoids with promising neuroprotective potential","volume":"p. bph.15185","author":"Stone","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.jconrel.2022.09.058_bb0470","first-page":"289","article-title":"The effect of poly(lactic-co-glycolic acid) (PLGA) coating on the mechanical, biodegradable, bioactive properties and drug release of porous calcium silicate scaffolds","volume":"22","author":"Zhao","year":"2012","journal-title":"Biomed. Mater. Eng."},{"issue":"2","key":"10.1016\/j.jconrel.2022.09.058_bb0475","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/1061186X.2017.1354002","article-title":"Neuroprotective effects of a biodegradable poly(lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: a potential nanotherapy for Alzheimer\u2019s disease?","volume":"26","author":"Aalinkeel","year":"2018","journal-title":"J. Drug Target."},{"issue":"3","key":"10.1016\/j.jconrel.2022.09.058_bb0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032616","article-title":"Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer\u2019s disease","volume":"7","author":"Mathew","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0485","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/nn405077y","article-title":"Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer\u2019s disease model via canonical Wnt\/\u03b2-Catenin pathway","volume":"8","author":"Tiwari","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0490","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejpb.2017.09.010","article-title":"Corrigendum to \u2018Andrographolide-loaded nanoparticles for brain delivery: Formulation, characterisation and in vitro permeability using hCMEC\/D3 cell line\u2019 [Eur. J. Pharm. Biopharm. 119 (2017) 253\u2013263]","volume":"120","author":"Guccione","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0495","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.colsurfb.2016.08.052","article-title":"Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer\u2019s disease","volume":"148","author":"Sun","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21691401.2017.1391822","article-title":"Phytol-loaded PLGA nanoparticle as a modulator of Alzheimer\u2019s toxic A\u03b2 peptide aggregation and fibrillation associated with impaired neuronal cell function","author":"Sathya","year":"2017","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0505","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as nanomedical devices","author":"Bozzuto","year":"2015","journal-title":"Int. J. Nanomedicine"},{"issue":"14","key":"10.1016\/j.jconrel.2022.09.058_bb0510","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.2174\/1381612822666160215154218","article-title":"Promising therapies for Alzheimer\u2019s disease","volume":"22","author":"Confaloni","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0515","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tibtech.2013.09.007","article-title":"Ligand-targeted liposome design: challenges and fundamental considerations","volume":"32","author":"Noble","year":"2014","journal-title":"Trends Biotechnol."},{"issue":"37","key":"10.1016\/j.jconrel.2022.09.058_bb0520","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.2174\/13816128113199990613","article-title":"Targeted drug delivery across the blood brain barrier in Alzheimer\u2019s disease","volume":"19","author":"Rocha","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.jconrel.2022.09.058_bb0525","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7439.1000171","article-title":"Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-\u03b2 peptide","volume":"4","author":"Sancini","year":"2013","journal-title":"J. Nanomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0530","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejmech.2014.04.050","article-title":"Multifunctional nanoliposomes with curcumin\u2013lipid derivative and brain targeting functionality with potential applications for Alzheimer disease","volume":"80","author":"Mourtas","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2022.09.058_bb0535","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijpharm.2013.03.046","article-title":"Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain","volume":"448","author":"Kakkar","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/4164872","article-title":"Comparative neuroprotective effects of dietary curcumin and solid lipid curcumin particles in cultured mouse neuroblastoma cells after exposure to A \u03b2 42","volume":"2017","author":"Maiti","year":"2017","journal-title":"Int. J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.jconrel.2022.09.058_bb0545","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s12035-013-8401-2","article-title":"Neuroprotective effects of resveratrol against A\u03b2 administration in rats are improved by lipid-core nanocapsules","volume":"47","author":"Frozza","year":"2013","journal-title":"Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.jconrel.2022.09.058_bb0550","doi-asserted-by":"crossref","first-page":"10418","DOI":"10.1007\/s11356-017-9789-4","article-title":"Biogenic synthesis of gold nanoparticles from Terminalia arjuna bark extract: assessment of safety aspects and neuroprotective potential via antioxidant, anticholinesterase, and antiamyloidogenic effects","volume":"25","author":"Suganthy","year":"2018","journal-title":"Environ. Sci. Pollut. Res."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0555","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jphotobiol.2018.11.008","article-title":"A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid \u03b2 aggregation in Alzheimer\u2019s disease","volume":"190","author":"Huo","year":"2019","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0560","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.biomaterials.2018.12.027","article-title":"Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer\u2019s disease","volume":"197","author":"Sun","year":"2019","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.jconrel.2022.09.058_bb0565","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1021\/am501341u","article-title":"Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce Amyloid-\u03b2 aggregation and cytotoxicity","volume":"6","author":"Zhang","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0570","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/nano11010070","article-title":"Recent advances in nanomicelles delivery systems","volume":"11","author":"Tawfik","year":"2020","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0575","first-page":"1","article-title":"Recent advances in nanomicelles delivery systems","volume":"11","author":"Tawfik","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0580","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuint.2015.07.026","article-title":"Curcumin micelles improve mitochondrial function in neuronal PC12 cells and brains of NMRI mice \u2013 Impact on bioavailability","volume":"89","author":"Hagl","year":"2015","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.jconrel.2022.09.058_bb0585","doi-asserted-by":"crossref","first-page":"1801586","DOI":"10.1002\/advs.201801586","article-title":"Microenvironment remodeling micelles for Alzheimer\u2019s disease therapy by early modulation of Activated Microglia","volume":"6","author":"Lu","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0590","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijbiomac.2020.06.058","article-title":"Self- assembled lactoferrin-conjugated linoleic acid micelles as an orally active targeted nanoplatform for Alzheimer\u2019s disease","volume":"162","author":"Agwa","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.jconrel.2022.09.058_bb0595","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1039\/C0SM00549E","article-title":"Edible nanoemulsions: fabrication, properties, and functional performance","volume":"7","author":"McClements","year":"2011","journal-title":"Soft Matter"},{"issue":"6","key":"10.1016\/j.jconrel.2022.09.058_bb0600","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.nano.2014.03.015","article-title":"Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: The case of genetic CJD","volume":"10","author":"Mizrahi","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0605","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.biopha.2017.08.074","article-title":"Thymoquinone-rich fraction nanoemulsion (TQRFNE) decreases A\u03b240 and A\u03b242 levels by modulating APP processing, up-regulating IDE and LRP1, and down-regulating BACE1 and RAGE in response to high fat\/cholesterol diet-induced rats","volume":"95","author":"Ismail","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0610","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cbi.2017.07.014","article-title":"Beneficial effects of TQRF and TQ nano- and conventional emulsions on memory deficit, lipid peroxidation, total antioxidant status, antioxidants genes expression and soluble A\u03b2 levels in high fat-cholesterol diet-induced rats","volume":"275","author":"Ismail","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0615","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jconrel.2020.12.021","article-title":"Dendrimers against fungi \u2013 A state of the art review","volume":"330","author":"Mlynarczyk","year":"2021","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0620","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2018.04.032","article-title":"PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: a biophysical and nanotoxicological characterization","volume":"544","author":"Igart\u00faa","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0625","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.nano.2019.01.010","article-title":"Poly(propylene imine) dendrimers with histidine-maltose shell as novel type of nanoparticles for synapse and memory protection","volume":"17","author":"Aso","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0630","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2016.11.025","article-title":"Nanotechnology-based drug delivery systems for Alzheimer\u2019s disease management: technical, industrial, and clinical challenges","volume":"245","author":"Wen","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0635","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8147080","article-title":"Nanoparticle therapy is a promising approach in the management and prevention of many diseases: does it help in curing Alzheimer disease?","volume":"2020","author":"Kassem","year":"2020","journal-title":"J. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0640","series-title":"Nano Based Drug Delivery Systems: Recent Developments and Future Prospects","first-page":"1","author":"Patra","year":"2018"},{"issue":"2","key":"10.1016\/j.jconrel.2022.09.058_bb0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules22020277","article-title":"Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer\u2019s disease","volume":"22","author":"Loureiro","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0650","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2019.03.010","article-title":"Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)\/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe\/PS1dE9 Alzheimer\u2019s disease mice model","volume":"301","author":"Cano","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtice.2018.03.001","article-title":"Use of functionalized liposomes loaded with antioxidants to permeate the blood\u2013brain barrier and inhibit \u03b2-amyloid-induced neurodegeneration in the brain","volume":"87","author":"Kuo","year":"2018","journal-title":"J. Taiwan Inst. Chem. Eng."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.09.058_bb0660","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijpharm.2013.02.014","article-title":"Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A","volume":"446","author":"Patel","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0665","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/IJN.S151474","article-title":"Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease","volume":"13","author":"Meng","year":"2018","journal-title":"Int. J. Nanomedicine"},{"issue":"12","key":"10.1016\/j.jconrel.2022.09.058_bb0670","first-page":"1616","article-title":"An efficient encapsulation of thymoquinone using solid lipid nanoparticle for brain targeted drug delivery: physicochemical characterization, pharmacokinetics and bio-distribution studies","volume":"8","author":"Surekha","year":"2016","journal-title":"Int. J. Pharm. Clin. Res."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0675","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2014.11.014","article-title":"Neuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: Behavioral and biochemical evidence","volume":"747","author":"Sachdeva","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.jconrel.2022.09.058_bb0680","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejphar.2011.03.026","article-title":"Modulation of nitrergic pathway by sesamol prevents cognitive deficits and associated biochemical alterations in intracerebroventricular streptozotocin administered rats","volume":"659","author":"Misra","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2016.01.055","article-title":"Nanoformulated alpha-mangostin ameliorates Alzheimer\u2019s disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance","volume":"226","author":"Yao","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0690","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ijbiomac.2018.06.190","article-title":"In vitro neuroprotective effects of naringenin nanoemulsion against \u03b2-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation","volume":"118","author":"Md","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.09.058_bb0695","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijpharm.2016.11.061","article-title":"Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer\u2019s disease","volume":"517","author":"Moreno","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.jconrel.2022.09.058_bb0700","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1007\/s12035-016-0136-4","article-title":"Anthocyanin-loaded PEG-gold nanoparticles enhanced the neuroprotection of anthocyanins in an A\u03b21\u201342 mouse model of Alzheimer\u2019s disease","volume":"54","author":"Ali","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0705","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcis.2011.11.024","article-title":"Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells","volume":"368","author":"Manju","year":"2012","journal-title":"J. Colloid Interface Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0710","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1080\/10717544.2017.1410263","article-title":"Stealth lipid polymer hybrid nanoparticles loaded with rutin for effective brain delivery \u2013 comparative study with the gold standard (Tween 80): optimization, characterization and biodistribution","volume":"24","author":"Ishak","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0715","series-title":"The Effect of Baicalein-Loaded Y-Shaped Miktoarm Copolymer on Spatial Memory and Hippocampal Expression of DHCR24, SELADIN and SIRT6 Genes in Rat Model of Alzheimer","volume":"vol. 586","author":"Aghajanzadeh","year":"2020"},{"issue":"9","key":"10.1016\/j.jconrel.2022.09.058_bb0720","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/jnr.23244","article-title":"Baicalein reduces \u03b2-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer\u2019s disease transgenic mouse model","volume":"91","author":"Zhang","year":"2013","journal-title":"J. Neurosci. Res."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.09.058_bb0725","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2012.09.054","article-title":"Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies","volume":"439","author":"Martins","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2022.09.058_bb0730","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3233\/JAD-140078","article-title":"Camptothecin and its analogs reduce amyloid-\u03b2 production and amyloid-\u03b242-induced IL-1\u03b2 production","volume":"43","author":"Wang","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0735","first-page":"247","article-title":"Bacoside rich extract loaded solid lipid nanoparticles for Alzheimer\u2019s disease","volume":"20","author":"Kumar","year":"2020","journal-title":"Plant Arch."},{"issue":"6","key":"10.1016\/j.jconrel.2022.09.058_bb0740","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-020-01767-0","article-title":"Nobiletin as a molecule for formulation development: an overview of advanced formulation and nanotechnology-based strategies of nobiletin","volume":"21","author":"Kesharwani","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.jconrel.2022.09.058_bb0745","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1248\/bpb.b17-00364","article-title":"Nobiletin reduces intracellular and extracellular \u03b2-amyloid in iPS cell-derived Alzheimer\u2019s disease model neurons","volume":"41","author":"Kimura","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0750","article-title":"Systematically designed chitosan-coated solid lipid nanoparticles of ferulic acid for effective management of Alzheimer\u2019s disease: A preclinical evidence","volume":"205, no. May","author":"Saini","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"7","key":"10.1016\/j.jconrel.2022.09.058_bb0755","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.3390\/nu7075246","article-title":"Ferulic acid: a hope for Alzheimer\u2019s disease therapy from plants","volume":"7","author":"Sgarbossa","year":"2015","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.jconrel.2022.09.058_bb0760","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/02652048.2018.1441916","article-title":"Development and characterization of morin hydrate-loaded micellar nanocarriers for the effective management of Alzheimer\u2019s disease","volume":"35","author":"Singh","year":"2018","journal-title":"J. Microencapsul."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.09.058_bb0765","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijpharm.2017.07.080","article-title":"Anti-Alzheimer\u2019s potential of berberine using surface decorated multi-walled carbon nanotubes: a preclinical evidence","volume":"530","author":"Lohan","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.09.058_bb0770","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2013.05.005","article-title":"Characterization and in vitro permeation study of microemulsions and liquid crystalline systems containing the anticholinesterase alkaloidal extract from Tabernaemontana divaricata","volume":"452","author":"Chaiyana","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2022.09.058_bb0775","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbadis.2004.06.008","article-title":"Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer\u2019s \u03b2-amyloid fibrils in vitro","volume":"1690","author":"Ono","year":"2004","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"10","key":"10.1016\/j.jconrel.2022.09.058_bb0780","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1002\/jps.24557","article-title":"Intranasal piperine-loaded chitosan nanoparticles as brain-targeted therapy in Alzheimer\u2019s disease: optimization, biological efficacy, and potential toxicity","volume":"104","author":"Elnaggar","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"3\u20134","key":"10.1016\/j.jconrel.2022.09.058_bb0785","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/10717544.2013.779330","article-title":"Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for protection against scopolamine-induced amnesia","volume":"20","author":"Nagpal","year":"2013","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0790","series-title":"Development of a Novel Niosomal System for Oral Delivery of Ginkgo biloba Extract","first-page":"421","author":"Press","year":"2013"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0795","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.biopha.2017.11.047","article-title":"Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer\u2019s disease","volume":"97","author":"Kheradmand","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0800","first-page":"1","article-title":"Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for parkinson\u2019s disease","volume":"7, no. MAR","author":"Esteves","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0805","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.npep.2016.03.002","article-title":"Mitigating effect of chrysin loaded solid lipid nanoparticles against Amyloid \u03b225\u201335 induced oxidative stress in rat hippocampal region: an efficient formulation approach for Alzheimer\u2019s disease","volume":"58","author":"Vedagiri","year":"2016","journal-title":"Neuropeptides"},{"issue":"4","key":"10.1016\/j.jconrel.2022.09.058_bb0810","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3109\/10717544.2015.1089956","article-title":"Galantamine-loaded solid\u2013lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations","volume":"23","author":"Misra","year":"2016","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.jconrel.2022.09.058_bb0815","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/02652048.2012.717115","article-title":"Improved therapeutic performance of dithranol against psoriasis employing systematically optimized nanoemulsomes","volume":"30","author":"Raza","year":"2013","journal-title":"J. Microencapsul."},{"issue":"8","key":"10.1016\/j.jconrel.2022.09.058_bb0820","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3109\/10717544.2013.846433","article-title":"Nanoethosomes mediated transdermal delivery of vinpocetine for management of Alzheimers disease","volume":"22","author":"Moghaddam","year":"2015","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0825","first-page":"1","article-title":"Role of lipidic nanoparticles for management of Alzheimer\u2019s disease","volume":"2","author":"Sharma","year":"2016","journal-title":"Asian J. Biomater. Res."},{"issue":"8","key":"10.1016\/j.jconrel.2022.09.058_bb0830","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-020-01832-8","article-title":"Lipid nanoparticles improve the uptake of \u03b1-asarone into the brain parenchyma: formulation, characterization, in vivo pharmacokinetics, and brain delivery","volume":"21","author":"Ramalingam","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0835","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuroscience.2020.12.026","article-title":"Alpha-asarone improves cognitive function of APP\/PS1 mice and reducing A\u03b242, P-tau and neuroinflammation, and promoting neuron survival in the hippocampus","volume":"458","author":"Zeng","year":"2021","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.jconrel.2022.09.058_bb0840","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1021\/mp2005388","article-title":"Folic acid functionalized nanoparticles for enhanced oral drug delivery","volume":"9","author":"Roger","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0845","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004514.pub2","article-title":"Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people","author":"Malouf","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"10.1016\/j.jconrel.2022.09.058_bb0850","doi-asserted-by":"crossref","first-page":"10418","DOI":"10.1007\/s11356-017-9789-4","article-title":"Biogenic synthesis of gold nanoparticles from Terminalia arjuna bark extract: assessment of safety aspects and neuroprotective potential via antioxidant, anticholinesterase, and antiamyloidogenic effects","volume":"25","author":"Suganthy","year":"2018","journal-title":"Environ. Sci. Pollut. Res."},{"issue":"May","key":"10.1016\/j.jconrel.2022.09.058_bb0855","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.lfs.2018.08.046","article-title":"Silver nanoparticles from leaf extract of Mentha piperita: Eco-friendly synthesis and effect on acetylcholinesterase activity","volume":"209","author":"Khatoon","year":"2018","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2022.09.058_bb0860","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jep.2005.09.032","article-title":"Screening of plants used in Danish folk medicine to treat memory dysfunction for acetylcholinesterase inhibitory activity","volume":"104","author":"Adsersen","year":"2006","journal-title":"J. Ethnopharmacol."},{"issue":"11","key":"10.1016\/j.jconrel.2022.09.058_bb0865","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/jphp.12460","article-title":"Development of glutathione-conjugated asiatic acid-loaded bovine serum albumin nanoparticles for brain-targeted drug delivery","volume":"67","author":"Raval","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0870","article-title":"Pharmacological properties, molecular mechanisms, and pharmaceutical development of asiatic acid: a pentacyclic triterpenoid of therapeutic promise","volume":"9","author":"Meeran","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.jconrel.2022.09.058_bb0875","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40199-018-0221-5","article-title":"Nicotinamide loaded functionalized solid lipid nanoparticles improves cognition in Alzheimer\u2019s disease animal model by reducing Tau hyperphosphorylation","volume":"26","author":"Vakilinezhad","year":"2018","journal-title":"DARU, J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2022.09.058_bb0880","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/17425247.2018.1471058","article-title":"Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region","volume":"15","author":"Agrawal","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.jconrel.2022.09.058_bb0885","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.apjtm.2016.01.014","article-title":"Anti-Alzheimer\u2019s disease potential of coumarins from Angelica decursiva and Artemisia capillaris and structure-activity analysis","volume":"9","author":"Ali","year":"2016","journal-title":"Asian Pac J Trop Med"},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0890","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11010008","article-title":"Intranasal delivery of genistein-loaded nanoparticles as a potential preventive system against neurodegenerative disorders","volume":"11","author":"Rassu","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0895","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.ijbiomac.2017.08.057","article-title":"Size optimization and in vitro biocompatibility studies of chitosan nanoparticles","volume":"104","author":"Thandapani","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0900","series-title":"Neuroprotective Mechanisms of Puerarin in Central Nervous System Diseases: Update","first-page":"1","author":"Yu","year":"2021"},{"issue":"7","key":"10.1016\/j.jconrel.2022.09.058_bb0905","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.nano.2013.12.001","article-title":"Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect A\u03b2 aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease","volume":"10","author":"Bana","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"March","key":"10.1016\/j.jconrel.2022.09.058_bb0910","doi-asserted-by":"crossref","first-page":"110948","DOI":"10.1016\/j.colsurfb.2020.110948","article-title":"Deciphering the anti-apoptotic potential of \u03b1-bisabolol loaded solid lipid nanoparticles against A\u03b2 induced neurotoxicity in Neuro-2a cells","volume":"190","author":"Sathya","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0915","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.molliq.2018.05.075","article-title":"\u03b1-Bisabolol loaded solid lipid nanoparticles attenuates A\u03b2 aggregation and protects Neuro-2a cells from A\u03b2 induced neurotoxicity","volume":"264","author":"Sathya","year":"2018","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0920","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.2147\/IJN.S239608","article-title":"Transferrin-modified osthole PEGylated liposomes travel the blood-brain barrier and mitigate alzheimer\u2019s disease-related pathology in APP\/PS-1 mice","volume":"15","author":"Kong","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.09.058_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119553","article-title":"Cationic biopolymer functionalized nanoparticles encapsulating lutein to attenuate oxidative stress in effective treatment of Alzheimer\u2019s disease: a non-invasive approach","volume":"586","author":"Dhas","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"October","key":"10.1016\/j.jconrel.2022.09.058_bb0930","first-page":"2021","article-title":"Neuroprotective effects of maize tetrapeptide-anchored gold nanoparticles in Alzheimer\u2019s disease","volume":"200","author":"Zhang","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1\u20133","key":"10.1016\/j.jconrel.2022.09.058_bb0935","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0927-7757(98)00309-4","article-title":"Practical preparation of anionic mercapto ligand-stabilized gold nanoparticles and their immobilization","volume":"149","author":"Yonezawa","year":"1999","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0940","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ijbiomac.2020.02.041","article-title":"Silymarin encapsulated nanoliquid crystals for improved activity against beta amyloid induced cytotoxicity","volume":"149","author":"Singh","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.jconrel.2022.09.058_bb0945","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1166\/jbn.2013.1560","article-title":"Formulation and characterization of nanostructured lipid carrier of ubiquinone (Coenzyme Q10)","volume":"9","author":"Nanjwade","year":"2013","journal-title":"J. Biomed. Nanotechnol."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.09.058_bb0950","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2004.11.003","article-title":"Protective properties of melatonin-loaded nanoparticles against lipid peroxidation","volume":"289","author":"Schaffazick","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.jconrel.2022.09.058_bb0955","doi-asserted-by":"crossref","first-page":"10001","DOI":"10.1039\/C5RA19113K","article-title":"Nose to brain delivery of astaxanthin-loaded solid lipid nanoparticles: Fabrication, radio labeling, optimization and biological studies","volume":"6","author":"Chandra Bhatt","year":"2016","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0960","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.foodhyd.2007.04.009","article-title":"Preparation of nanodispersions containing \u03b2-carotene by solvent displacement method","volume":"22","author":"Ribeiro","year":"2008","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.jconrel.2022.09.058_bb0965","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8825640","article-title":"Multiple-coated PLGA nanoparticles loading triptolide attenuate injury of a cellular model of Alzheimer\u2019s disease","volume":"2021","author":"Jia","year":"2021","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"10.1016\/j.jconrel.2022.09.058_bb0970","first-page":"329","article-title":"Role of nanoparticles for production of smart herbal drug-an overview","volume":"4","author":"Mathur","year":"2013","journal-title":"Indian J. Nat. Prod. Resour."},{"issue":"1","key":"10.1016\/j.jconrel.2022.09.058_bb0975","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/10717544.2014.910566","article-title":"Preparation of surface multiple-coated polylactide acid drug-loaded nanoparticles for intranasal delivery and evaluation on its brain-targeting efficiency","volume":"23","author":"Bian","year":"2016","journal-title":"Drug Deliv."},{"issue":"2","key":"10.1016\/j.jconrel.2022.09.058_bb0980","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s12668-020-00819-w","article-title":"Formulation development and characterization of Withaferin-A loaded polymeric nanoparticles for Alzheimer\u2019s disease","volume":"11","author":"Madhu","year":"2021","journal-title":"Bionanoscience"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922006617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922006617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:37:51Z","timestamp":1759163871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922006617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":196,"alternative-id":["S0168365922006617"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.09.058","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.09.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}